Skip to main content

NeuBase Therapeutics Inc. Common Stock (NBSE)

About The Company

NBSE Stock Market Logo

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington’s Disease, Myotonic Dystrophy and Familial Parkinson’s Disease among others.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

NeuBase Therapeutics Inc. (NBSE) Latest News

Company Contact & Address (NBSE)

Corporate Headquarters Phone Website
United States
+1 646 450-1790 Official NBSE Website

NBSE Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ NBSE

Jobs & Employment at NeuBase Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the employment, jobs & careers info.

Related & Similar Stock Symbols

HCAT Stock Market Price & News


Health Catalyst Inc Common Stock

JHI Stock Market Price & News


John Hancock Investors Trust Common Stock

TDS^V Stock Market Price & News


Telephone and Data Systems Inc. Depositary Shares …